Meredith Langguth
Psychiatric/Mental Health · Austin, TXNPI 1699424598
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 236 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,766 and has fallen 67.4% since, to $903 in 2025. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 236 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$699
- Corium, LLC$667
- Johnson & Johnson$461
- Alkermes, Inc.$437
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$379
- plus $2K from 16 others
What the payments were for
- Food & beverage$5,553100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $1,007 |
| Otsuka America Pharmaceutical, Inc. | 27 | $699 |
| Corium, LLC | 27 | $667 |
| Johnson & Johnson | 21 | $461 |
| Alkermes, Inc. | 8 | $437 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $379 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $264 |
| Lundbeck LLC | 14 | $231 |
| Teva Pharmaceuticals USA, Inc. | 6 | $216 |
| Idorsia Pharmaceuticals US Inc | 6 | $190 |
| Axsome Therapeutics, Inc. | 8 | $168 |
| Sumitomo Pharma America, Inc. | 1 | $129 |
| Lilly USA, LLC | 1 | $116 |
| Supernus Pharmaceuticals, Inc. | 5 | $102 |
| Neurocrine Biosciences, Inc. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Noven Therapeutics, LLC | 4 | $78 |
| Biogen | 4 | $72 |
| Bausch Health US, LLC | 3 | $71 |
| Neos Therapeutics, LP | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| TMS Neurohealth Centers Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,553 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Austin
- Jaime Nelson DensonAustin$88K
- Camille WatsonAustin$34K
- Suzanne GranthamAustin$31K
- Lin CaiAustin$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.